Internal Medicine · Brooklyn, NY
NPI
1306807490
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3080 Brighton 13th St
Brooklyn, NY, 11235
Phone (718) 769-1010
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
3,772 prescriptions
Company payments, 2025
$224
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Marika D Cherfas prescribed most often to Medicare patients was Zenpep (Lipase/Protease/Amylase), with 198 prescriptions and refills. In total Marika D Cherfas wrote 3,772 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Zenpep Lipase/Protease/Amylase | 198 | 198 | 24 | $450K |
| Vascepa Icosapent Ethyl | 194 | 202 | 25 | $67K |
| Restasis Cyclosporine | 159 | 163 | 18 | $100K |
| Dexilant Dexlansoprazole | 152 | 158 | 17 | $46K |
| Linzess Linaclotide | 145 | 147 | 19 | $75K |
| Myrbetriq Mirabegron | 142 | 142 | 14 | $62K |
| Diclofenac Sodium Generic | 119 | 125 | 14 | $104K |
| Jublia Efinaconazole | 110 | 110 | 11 | $158K |
| Mesalamine Generic | 91 | 91 | Under 11 | $10K |
| Ztlido Lidocaine | 71 | 71 | 11 | $33K |
| Amlodipine Besylate Generic | 71 | 83 | Under 11 | $115 |
| Naftin Naftifine Hcl | 65 | 65 | Under 11 | $34K |
| Namzaric Memantine Hcl/Donepezil Hcl | 60 | 60 | Under 11 | $33K |
| Breo Ellipta Fluticasone/Vilanterol | 60 | 60 | Under 11 | $23K |
| Crestor Rosuvastatin Calcium | 59 | 59 | Under 11 | $16K |
Brand drugs: 2,500 claims; generic drugs: - claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marika D Cherfas $224 ($224 in general payments such as food, travel and fees) from 2 companies. The largest payer was Axsome Therapeutics, Inc. with $179.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.